Financials
- Market Capitalization 4.2 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.56
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1425 | VKTX Viking Therapeutics, Inc. - Common Stock | 38.12 USD | -1.90% | -2.48% | +30.82% | +20.06% | 4.43 B USD | ||
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.50 USD | -2.75% | -2.52% | +20.85% | +16.23% | 4.37 B USD | ||
| 1478 | TNGX Tango Therapeutics, Inc. - Common Stock | 28.36 USD | -8.69% | -6.43% | -9.48% | +358.16% | 4.10 B USD | ||
| 1527 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.28 USD | -5.62% | -5.00% | +6.74% | -8.24% | 3.89 B USD |